Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-β1 and interleukin 10 in activated microglial cultures

Journal of Neuroimmunology

Volumn 82, Issue 1, 1998, Pages 31-39

  Minghetti, Luisa ^a   Polazzi, Elisabetta ^a   Nicolini, Alessia ^a   Levi, Giulio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Interferon ; Nitric oxide; Nitric oxide synthase; PGH synthase; Prostanoids; Rat brain macrophages

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; DOWN REGULATION; FEEDBACK SYSTEM; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MICROGLIA; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; BRAIN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INHIBITORS; INTERFERON TYPE II; INTERLEUKIN-10; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OMEGA-N-METHYLARGININE; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032005921     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00185-9     Document Type: Article

References (64)

1. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663:1994;237-243.
2. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1991;1549-1555.
3. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
4. Cannella B., Gao Y.L., Brosnan C.F., Raine C.S. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;735-746.
5. 2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. Neurosci. Lett. 160:1993;106-108.
6. Cazevieille C., Muller A., Meynier F., Dutrait N., Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24:1994;395-398.
7. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell death injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
8. Chao C.C., Gekker G., Sheng W.S., Hu S., Tsang M., Peterson P.K. Priming effect of morphine on the production of tumor necrosis factor-α by microglia: Implications in respiratory burst activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther. 269:1994;198-203.
9. Chao C.C., Hu S.X., Sheng W.S., Tsang M., Peterson P.K. Tumor necrosis factor-α mediates the release of bioactive transforming growth factor-β in murine microglial cell cultures. Clin. Immunol. Immunopathol. 77:1995;358-365.
10. Chomarat P., Rissoan M.C., Banchereau J., Miossec P. Interferon γ inhibits interleukin 10 production by monocytes. J. Exp. Med. 177:1993;523-527.
11. Constam D., Philipp J., Malipiero U., Tendijke P., Schachner M., Fontana A. Differential expression of transforming growth factor-beta1, factor-beta2, and factor-beta3 by glioblastoma cells, astrocytes, and microglia. J. Immunol. 148:1992;1404-1410.
12. Cunha F.Q., Moncada S., Liew F.Y. Interleukin 10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182:1992;3578-3582.
13. Cupp C., Taylor P.T., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 8:1993;2231-2236.
14. da Cunha A., Jefferson J.A., Jackson R.W., Vitkovic L. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J. Neuroimmunol. 42:1993;71-86.
15. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophages deactivating factor and transforming growth factor-β1, -β2 and -β3 inhibit induction of macrophages nitrogen oxide synthesis by IFN-γ J. Immunol. 145:1990;940-944.
16. Espinoza-Delgado I., Bosco M.C., Musso T., Mood K., Ruscetti F.W., Longo D.L., Varesio L. Inhibitory cytokine circuits involving transforming growth factor-β, interferon-γ, and interleukin-2 in human monocyte activation. Blood. 83:1994;3332-3338.
17. 2a-receptors. Glia. 18:1996;152-160.
18. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-β1 is an organizer of response to neurodegeneration. J. Cell Biochem. 53:1993;314-322.
19. Fretland D.J. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. Prostaglandins Leukot. Essent. Fatty Acids. 45:1992;249-257.
20. Gallo P., Sivieri S., Rinaldi L., Yan X.-B., Lolli F., De Rossi A., Tavolato B. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J. Neurol. Sci. 126:1994;49-53.
21. 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J. Cell. Physiol. 159:1994;67-75.
22. Griffin D.E., Wesselingh S.L., McArthur J.C. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:1994;592-597.
23. 2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells. FEBS Lett. 413:1997;314-318.
24. Habib A., Créminon C., Frobert Y., Grassi J., Pradelles P., Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of cyclooxygenase-2. J. Cell Biol. 40:1993;23448-23454.
25. Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299:1996;125-140.
26. Hu S., Sheng W.S., Peterson P.K., Chao C.C. Cytokine modulation of murine microglial cell superoxide production. Glia. 13:1995;45-50.
27. 2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. 197:1993;1465-1474.
28. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
29. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
30. Kiefer R., Gold R., Gehrmann J., Lindholm D., Wekerle H., Kreutzberg G.W. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J. Neurosci. Res. 36:1993;391-398.
31. Kiefer R., Streit W.J., Toyka K.V., Kreutzberg G.W., Hartung H.-P. Transforming growth factor-β1: A lesion-associated cytokine of the nervous system. Int. J. Dev. Neurosci. 13:1995;331-339.
32. Kramer J.M., Koornneef I., De Laat S.W., van den Eijnden-van Raaij A.J.M. TGF-β1 induces phosphorylation of the cyclic AMP responsive element binding protein in ML-CCI64 cells. EMBO J. 10:1991;1083-1089.
33. Kreisberg J.I., Radnik R.A., Kreisberg S.H. Phosphorylation of cAMP responsive element binding protein after treatment of mesangial cells with high glucose plus TGFβ or PMA. Kidney International. 50:1996;805-810.
34. Levi G., Patrizio M., Bernardo A., Petrucci T.C., Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. USA. 90:1993;1541-1545.
35. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:1992;395-400.
36. Lodge P.A., Sriram S. Regulation of microglial activation by TGF-β, IL-10, and CSF-1. J. Leukoc. Biol. 60:1996;502-508.
37. 1 after hypoxic-ischaemic brain injury. Neuroreport. 5:1994;901-904.
38. 2 and cyclic AMP-elevating agents. J. Neuroimmunol. 72:1997;83-93.
39. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
40. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
41. Merrill J.E., Zimmerman R.P. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhabitable by TGFβ Glia. 4:1991;327-331.
42. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J. Biol. Chem. 269:1994;21322-21329.
43. Minghetti L., Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65:1995;2690-2698.
44. Minghetti L., Polazzi E., Nicolini A., Créminon C., Levi G. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. 66:1996;1963-1970.
45. 2 and by cyclooxigenase inhibitors. Glia. 19:1997;152-160.
46. 2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur. J. Neurosci. 9:1997;934-940.
47. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
48. Moore K.W., O'Garra A., De Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
49. Morgan T.E., Nichols N.R., Pasinetti G.M., Finch C.E. TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120:1993;291-301.
50. Navikas V., Link H. Cytokines and pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
51. Orlandi M., Bartolini G., Chiricolo M., Minghetti L., Franceschi C., Tomasi V. Prostaglandin and thromboxane biosynthesis in isolated platelet-free human monocytes. A modified procedure for characterisation of the prostaglandin spectrum produced by resting and activated microglia. Prostaglandins Leukot. Med. 18:1985;205-216.
52. 2 production. Glia. 21:1997;183-193.
53. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today. 12:1991;349-352.
54. 1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages. J. Leukoc. Biol. 55:1994;192-200.
55. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Poser S. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
56. Slepko N., Levi G. Progressive activation of adult microglial cells in vitro. Glia. 16:1996;241-246.
57. Shimizu T., Wolfe L.S. Arachidonic acid cascade and signal transduction. J. Neurochem. 55:1990;1-15.
58. 2. J. Exp. Med. 180:1994;2365-2370.
59. 2 and a β-adrenergic agonist. Glia. 11:1994;383-386.
60. Tracey W.R. Spectrophotometric determination of nitrogen oxide using azo dyes. Neuroprotocols. 1:1992;125-131.
61. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:1995;775-779.
62. Wahl S.M., Allen J.B., McCartney-Francis N., Morganti-Kossmann M.C., Kossmann T., Ellingsworth L., Mai U.E.H., Mergenhagen S.E., Orestein J.M. Macrophage- and astrocyte-derived transforming growth factor-β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173:1991;981-991.
63. Weissmann G. Prostaglandins as modulators rather than mediators of inflammation. J. Lipid Mediat. 6:1993;275-286.
64. Xiao B.G., Zhang G.X., Ma C.G., Link H. Transforming growth factor-beta 1 (TGF-β1)-mediated inhibition of glial cell proliferation and down-regulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-γ). Clin. Exp. Immunol. 103:1996;475-481.